HL7® FHIR® Te Aho o Te Kahu, Cancer Control Agency Implementation Guide
0.1.0 - CI Build

HL7® FHIR® Te Aho o Te Kahu, Cancer Control Agency Implementation Guide, published by Te Aho o Te Kahu, Cancer Control Agency. This is not an authorized publication; it is the continuous build for version 0.1.0. This version is based on the current content of https://github.com/HL7NZ/cca/ and changes regularly. See the Directory of published versions

Examples

Colorectal Adjuvant FOLFOX (a7)

A drug treatment regimen for Colorectal cancer

Link to example
Regimen type Folfox
focus Colorectal cancer http://snomed.info/sct 781382000

Support factors

Factor Value
Diarrhoea risk low
AntiFungal Prophylaxis low
Hypersensitivity / Infusion related reaction ris low

Related artifacts

Type Display Url
citation test http://www.ncbi.nlm.nih.gov/pubmed/23434
citation test2 http://www.ncbi.nlm.nih.gov/pubmed/34324

Regimen details

Cycle 1 Administration of Cabergoline and Tragacanth. Cycle length 14 days
Cycle length: 14 d Repeat:None

Action 1 2mg of Cabergoline daily on days 1 and 4 by IV Infusion over 20 minutes
Day 1 Specific instructions for the day 1 administration
Day 4 Specific instructions for the day 4 administration

Action 2 3mg of Tragacanth daily on days 2,3 and 4 by IV Infusion over 3 hours
Day 2 Specific instructions for the day 2 administration
Day 3 Specific instructions for the day 3 administration
Day 4 Specific instructions for the day 4 administration

Summary of administration by day
Day 1
2mg of Cabergoline daily on days 1 and 4 by IV Infusion over 20 minutes
Specific instructions for the day 1 administration
Day 2
3mg of Tragacanth daily on days 2,3 and 4 by IV Infusion over 3 hours
Specific instructions for the day 2 administration
Day 3
3mg of Tragacanth daily on days 2,3 and 4 by IV Infusion over 3 hours
Specific instructions for the day 3 administration
Day 4
2mg of Cabergoline daily on days 1 and 4 by IV Infusion over 20 minutes
Specific instructions for the day 4 administration
3mg of Tragacanth daily on days 2,3 and 4 by IV Infusion over 3 hours
Specific instructions for the day 4 administration